Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Bone Density in Liver Transplant Patients
NCT00114556Phase 4Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Feb 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in osteoporosis comparing Zoledronate Group with Placebo Group (2 arms). Primary endpoint: Bone Density at 3 months post-transplantation. Started Feb 2000; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00114556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114556.